What is the ROE (Return on Equity) of ImpediMed this year?
The ROE of ImpediMed this year is -0.34 undefined.
ImpediMed ROE 2024
ImpediMed ROE
-0.34
Ticker
IPD.AX
ISIN
AU000000IPD8
In 2024, ImpediMed's return on equity (ROE) was -0.34, a -13.43% increase from the -0.39 ROE in the previous year.
ImpediMed Aktienanalyse
What does ImpediMed do?
ImpediMed Ltd is an Australian company specializing in medical devices and technologies. They were founded in 1999 and have their headquarters in Brisbane, Australia. The company is a leading provider of bioimpedance measurement devices for the diagnosis, monitoring, and treatment of lymphatic, cardiac, and other medical conditions. They have a wide range of products used in various medical fields, including oncology, lymphology, and cardiology. Their main business model is based on the development and marketing of their bioimpedance measurement devices. They also provide training and support for medical personnel to optimize the use of their devices. ImpediMed specializes in the diagnosis and treatment of lymphedema in the oncology sector, particularly using their highly precise L-Dex® device. They also analyze body composition in the cardiology sector to determine the risk of heart diseases and develop personalized treatment approaches. In recent years, ImpediMed has expanded into the European market, particularly in lymphedema diagnosis and treatment. Overall, ImpediMed Ltd is an innovative company that focuses on medical devices and technologies for the diagnosis and monitoring of cardiac and lymphatic diseases. They provide important diagnostic capabilities to medical professionals and continue to focus on growth and expansion. ImpediMed ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding ImpediMed's Return on Equity (ROE)
ImpediMed's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing ImpediMed's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
ImpediMed's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in ImpediMed’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about ImpediMed stock
How has the Return on Equity (ROE) of ImpediMed developed compared to the previous year?
The ROE of ImpediMed has increased by -13.43% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of ImpediMed?
A high ROE indicates that ImpediMed generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of ImpediMed?
A low ROE can indicate that ImpediMed is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of ImpediMed affect the company?
A change in ROE (Return on Equity) of ImpediMed can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of ImpediMed?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of ImpediMed?
Some factors that can influence ImpediMed's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does ImpediMed pay?
Over the past 12 months, ImpediMed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ImpediMed is expected to pay a dividend of 0 AUD.
What is the dividend yield of ImpediMed?
The current dividend yield of ImpediMed is .
When does ImpediMed pay dividends?
ImpediMed pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ImpediMed?
ImpediMed paid dividends every year for the past 0 years.
What is the dividend of ImpediMed?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ImpediMed located?
ImpediMed is assigned to the 'Health' sector.
Wann musste ich die Aktien von ImpediMed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ImpediMed from 8/18/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 8/18/2024.
When did ImpediMed pay the last dividend?
The last dividend was paid out on 8/18/2024.
What was the dividend of ImpediMed in the year 2023?
In the year 2023, ImpediMed distributed 0 AUD as dividends.
In which currency does ImpediMed pay out the dividend?
The dividends of ImpediMed are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von ImpediMed
Our stock analysis for ImpediMed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ImpediMed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
